ERIC DUFFIELD: Open Payments
NPI 1245427004 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 50 payments from 17 companies in 2025. Trend: 2023 $1,190 · 2024 $574 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $250 |
| Novo Nordisk Inc | 5 | $103 |
| UCB, Inc. | 3 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $91 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Lilly USA, LLC | 3 | $47 |
| Insmed, Inc. | 2 | $43 |
| Grifols USA, LLC | 2 | $39 |
| GENZYME CORPORATION | 1 | $35 |
| Baxter Healthcare | 1 | $25 |
Products named: VRAYLAR, Bimzelx, OFEV, TRELEGY ELLIPTA, UBRELVY, RINVOQ, Arikayce, Ozempic.
Industry payments across MI — which companies pay providers there.
